Loading...
You are here:  Home  >  News  >  Business  >  Current Article

Theradiag Announces Its Results for the First Half of 2021

By   /  September 20, 2021  /  Comments Off on Theradiag Announces Its Results for the First Half of 2021

    Print       Email


CROISSY-BEAUBOURG, France–()–Regulatory News:

THERADIAG (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and Theranostics, today announces its half-year results to June 30, 2021, as approved by the Board of Directors on September 16, 2021.

H1 2021 results

In thousands of euros

H1 2021

H1 2020

% change

Revenue

5,482

4,871

+12.5 %

of which: Theranostics

2,766

2,410

+14.7 %

of which: IVD

2,716

2,461

+10.4 %

Operating income/(loss)

(178)

(423)

+57.9 %

Income/(loss) before tax and non-recurring items

(206)

(358)

+42.4 %

Net income/(loss) before non-recurring items

(23)

Click here to view the original article.

    Print       Email